Please see the following letter addressed to the WHO regarding Mary Beth Pfeiffer’s latest article in the Huffington Post ________________________________________ From: "Carl Tuttle" To: "Ian Michael SMITH" Cc: aylwardb@who.int, renm@who.int, engelsd@who.int, briands@who.int, jfacar7@hotmail.com, "antoine andremont" , "Peter Collignon" , "John conly" , pidonado@corpoica.org.co, pjcray@ncsu.edu, galasmf@yahoo.com.ar, rshe@food.dtu.dk, "Rebecca irwin" , maislam@icddrb.org, skariuki@kemri.org, hyosun610@gmail.com, smcewen@uoguelph.ca, "gerard moulin" , "arno muller pro" , antongandjio@yahoo.fr, "patrick otto" , ranjithdpperera@hotmail.com, flaviarossi61@gmail.com, hmscott@cvm.tamu.edu, "j wagenaar" , "rosa peran" , "HendrikJan Ormel" , "e erlacher-vindel" , "lothar kreienbrock" , gmatar@aub.edu.lb, "Takiyah Ball" , aidarakanea@who.int, mumforde@who.int, pereze@pan.ops-oms.org, seoy@who.int, jstelling@whonet.org Sent: Saturday, September 10, 2016 10:33:57 AM Subject: CDC Says Fewer Suffer After Lyme Disease. Doesn’t Say, If Treated Early Sept 10, 2016 World Health Organization Avenue Appia 20 1211 Geneva 27 Switzerland Attn: Ian Smith MD, Executive Director of the Director-General's Office Dear Dr Smith, I would like to call attention to the following article recently published in the Huffington Post: CDC Says Fewer Suffer After Lyme Disease. Doesn’t Say, If Treated Early. http://www.huffingtonpost.com/mary-beth-pfeiffer/cdc-citing-one-study-of-e_b_11877020.html 09/08/2016 Mary Beth Pfeiffer Mary Beth Pfeiffer is a long-time investigative journalist who is writing a book on the global spread of Lyme and other tick-borne diseases. Excerpt: “For at least five years, the U.S. Centers for Disease Control and Prevention has officially stated that 10 to 20 percent of patients treated for Lyme disease — some 30,000 to 60,000 of 300,000 infected yearly — “will have lingering symptoms of fatigue, pain, or joint and muscle aches,” even after supposedly curative antibiotic treatment.” “But quietly, without peer review or formal announcement, the agency has decided that the actual percentage is much smaller — half or a quarter as much. The decision was made, officials told me, based on a study that showed less than 5 percent of Lyme patients exhibit ongoing symptoms after treatment.” _____________________ Here is the study used by the CDC to revise the numbers from 10-20% to only 5%: Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease. Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, Cooper D, Nadelman RB, Visintainer P, Schwartz I, Wormser GP. On July 15, 2016 I sent you an email regarding this Wormser study: Excerpt from my email to Dr. Smith: “This study excluded the sickest of the patient population focusing on the acute stage of disease after early treatment. The misleading results of Dr Wormser’s study is then assumed to apply to the entire patient population giving the impression that Lyme is a simple nuisance disease (aches and pains of daily living) and patients who are severely disabled are somehow delusional. A complaint was filed with the Office of Research Integrity: Scientific misconduct or criminal offense? https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/14006106 Additional excerpt from my email to Dr Smith: 1. A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library Front. Microbiol., 23 May 2016 http://dx.doi.org/10.3389/fmicb.2016.00743 Jie Feng, Wanliang Shi, Shuo Zhang, David Sullivan, Paul G. Auwaerter and Ying Zhang Excerpt from the Frontiers in Microbiology article: “Under experimental stress conditions such as starvation or antibiotic exposure, Borrelia burgdorferi can develop round body forms, which are a type of persister bacteria that appear resistant in vitro to customary first-line antibiotics for Lyme disease.” 2. Standard antibiotic treatment for Lyme disease does not kill persistent Borrelia bacteria. http://droopyyoupi.blogspot.com/2015/08/standart-antibiotic-treatment-for-lyme.html Quote from Dr. Ying Zhang: -What has tuberculosis and Borrelia burgdorferi in common? In the late stage of the disease occurs persistent (tolerant) bacteria, which essentially means that the bacteria lasts and lasts and lasts. They protect themselves against antibiotics and are difficult to treat. - Both Borrelia burgdorferi and tuberculosis is relatively easy to cure in the early stages, even with the use of one antibiotic. In the late stage it is impossible to cure the disease with the same type of treatment in the acute phase, said Dr. Ying Zhang when he visited the year NorVect conference. -Dr. Ying Zhang is a professor at the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. ___________________ Dr. Smith…… The focus here in the United States has always been on the acute stage of disease while the horribly disabled are avoided and ignored. You of all people with a background in tuberculosis shouldn’t be fooled by this nonsense of collusion to deny a life-altering/life-threatening disease. http://www.who.int/dg/adg/smith/en/ I really don’t know how much more obvious this can get but what has been deceptively established here in the United States is already producing global consequences. This is why I have been forwarding email after email for the past two months to gain your attention into the wrongful handling of Lyme disease. From the World Health Organization website: Who we are, what we do http://www.who.int/about/en/ “Our goal is to build a better, healthier future for people all over the world. Working through offices in more than 150 countries, WHO staff work side by side with governments and other partners to ensure the highest attainable level of health for all people.” I ask the following question of you Dr. Smith; “Is the WHO partnering with the U.S. Centers for Disease Control while turning a blind eye to the wrongful handling of Lyme disease?” Respectfully submitted, Carl Tuttle Hudson, NH USA Lyme Disease: Call for a “Manhattan Project” to Combat the Epidemic Raphael B. Stricker and Lorraine Johnson http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879353/